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Lack of functional dystrophin causes 
severe Duchenne muscular dystrophy 
(DMD). While dystrophin's native function is 
still unknown, its subsarcolemmal location 
and association with the cytoskeleton and 
membrane-spanning entities suggests a role in 
the mechanical regulation of membrane stress 
during muscle contraction-relaxation cycles. 
Phenotype rescue by expression of truncated 
forms of dystrophin in dystrophin deficient 
mdx mice has shown that some parts of the 
rod-shaped domain of 24 spectrin-like repeats 
could be essential. We compared biophysical 
properties of the repeat 23 (R23) of human 
dystrophin rod domain and one double 
mutant in helix C, E2910V-N2912D 
encountered in a DMD. Basal CD and 
tryptophan fluorescence spectra were 
superimposable for both proteins while NMR 
spectra revealed mild change in tryptophan 
environment. Thermal denaturation analysis 
by CD showed that wild-type protein remains 
folded at 37°C, while the mutant is partly 
unfolded. Urea unfolding analysed by 
tryptophan fluorescence showed a decrease of 
mid-denaturing urea concentration for the 
mutant. Stopped-flow spectrophotometry 
showed that urea denatured WT R23 refolded 
much faster than the mutant. On the basis of 
3D structures built by homology molecular 
modelling, we discuss the modifications of 
stability induced by the double mutation. 
Taken together, our results show that a two-
amino acid mutation in repeat 23 of 
dystrophin rod domain, causing DMD, 
induces a significantly decreased stability of 
R23 repeat that may participate in 
mechanically weakened dystrophin-deficient 
muscle. These results represent a contribution 
to the functional dissection of the dystrophin 
protein, thus emphasizing the role of the 
dystrophin rod domain in muscle cell. 
 
Dystrophin-associated muscular dystrophies 
range from the severe Duchenne muscular 
dystrophy (DMD) to the milder Becker muscular 
dystrophy (BMD). Molecular genetic studies 
indicate that both disorders are the result of 
mutations in the huge gene that encodes 
dystrophin. Analysis of naturally occurring 
mutations demonstrates that approximately 
two-thirds of the mutations in DMD and BMD 
forms are intragenic partial deletions (1). Indeed, 
deletion of exons disrupting the reading frame 
leads to premature translational termination and 
absence of the protein in DMD cases. On the 
other hand, mutations maintaining the 
translational reading frame can lead to 
semi-functional microdystrophins in BMD cases 
(2,3). The remaining one-third of DMD/BMD 
patients have rare point mutations, such as micro 
deletions/insertions or substitutions of one or 
more nucleotides (4,5). Despite the potential 
importance of this source of information on 
protein behaviour in cells, the consequences of 
these mutations on biological properties of 
dystrophin are so far poorly documented, mainly 
due to the size and complexity of the protein’s 
cellular partnership. Dystrophin is a 427 kDa 
protein included within the multiproteic 
dystrophin glycoprotein complex (DGC), which 
spans the sarcolemma and links the actin 
cytoskeleton with the extracellular matrix of 
myofibres (6). The N-terminal part of dystrophin 
is reported as a globular actin binding domain 1 
(ABD1) containing two alpha-helical calponin 
 1  
homology domains linked by a central alpha-
helix (7). The C-terminal cysteine-rich domain of 
dystrophin is the binding region to the DGC 
through an interaction of its WW domain with a 
proline-rich motif of the cytoplasmic tail of 
beta-dystroglycan (8). In this way, dystrophin 
creates a link between the intracellular 
cytoskeleton and extracellular matrix, which 
leads to maintenance of cell integrity of the 
muscular membrane in regard to contraction and 
relaxation (6). The dystrophin rod domain is 
made up of a series of 24 weakly repeating units 
of 110 amino acids similar to the coiled coil 
repeats of spectrin, and is disrupted by four 
potential hinges that may ensure flexibility (9). 
These homologous sequence motifs have been 
proposed to form domains with a triple-helical 
bundle type structure (10,11). Primary sequence 
analysis and modelling studies have revealed the 
arrangement of the amino acid sequences of 
spectrin and dystrophin, which form repeating 
heptad patterns designated "a" to "g", as 
described previously (9,12,13). The hydrophobic 
"a" and "d" residues located in the inter-helical 
region stabilize each triple helical repeating unit 
adjacent to the helix. On the other hand, "e" and 
"g" residues are frequently charged, being 
located between the inter-helical region and the 
aqueous phase. Hence, these residues may form 
inter-helical salt bridges with "e" or "g" residues 
of opposite charge in an adjacent helix (12). 
To understand fully the biological role of 
the rod domain, further investigations are needed 
concerning the relationship between the 
sequences of the repeating units and their 
biochemical and biophysical properties. The 
study of cloned wild type or mutated repeating 
single units from spectrin-like proteins represents 
a first significant step forward in the 
investigation of the rod domain (14-20). 
Moreover, knowledge has been improved by 
work on micro and minidystrophins lacking one 
or several repeats (21-24). The roles of some 
parts of the potentially flexible rod domain are 
still largely unknown. Nevertheless, the repeats 
11 to 17 of the rod domain have been reported as 
a second actin-binding domain (ABD2) (23,25). 
The physiological functional importance of 
ABD2 remains to be elucidated since normal 
phenotype is restored in dystrophic mice with 
minidystrophins lacking the whole ABD2 
(22,26). On the other hand, it is noteworthy that 
the sub-domains R1-3 and R20-24, located 
between unstructured hinges 1- 2 and 3-4, 
respectively, are present in the phenotype-
restoring minidystrophin Δ17-48 found in a 
Becker patient (27). However, semifunctional 
microdystrophin genes have been constructed 
with as few as four spectrin-like repeats and 
three hinge regions (22). Additionally, the R1-3 
sub-domain has been shown to interact 
specifically with negative membrane lipids and 
was defined as lipid binding domain 1 (LBD1) 
(20). Binding to lipids by this part of the rod 
domain is strongly mediated through 
hydrophobic interactions between tryptophan 
residues in repeat 2 and aliphatic chains of 
phospholipid fatty acids (16). The proximal R1-3 
part of the rod domain could thus be involved in 
membrane adhesion, contributing to the 
modulation of membrane deformability in the 
muscle cell, as suggested by the “curvature 
sensitivity” of the R2 repeat (28). Lipid binding 
properties could be associated to shuttling of 
membrane reservoirs that should prevent rupture 
of the sarcolemma (29). Conversely, the distal 
R20-24 region of the rod domain lacks any 
known functional or binding activity (20). This 
region is located between hinges 3 and 4 in the 
rod domain, and it is thought to act as a passive 
linker or as a structural stabiliser of its adjacent 
beta dystroglycan binding domain. Its proximity 
with the beta-dystroglycan could contribute to 
proper mechanical behaviour of the DGC in 
muscle cells and ensure membrane conservation 
during muscle cell contraction and elongation 
cycles. The actual role of rigidity and flexibility 
of the whole rod domain, as well as that of 
individual single repeats, remains largely 
unknown. The comparative analysis of data from 
rod domains of spectrin versus dystrophin 
repeats yields incomplete information due to the 
fact that spectrin repeats are involved in alpha 
and beta spectrin heterodimerisation, while no 
part of the dystrophin rod domain has a known 
dimer-forming role (30). 
Most of the rare BMD point mutations 
correspond to i) missense mutations in the N-
terminal or C-terminal domains, or ii) splice-site 
mutations that probably act, like BMD deletions, 
via the production of interstitially deleted in-
frame transcripts. Only few missense DMD- or 
BMD-linked point mutations have been reported 
in the dystrophin gene and 70 of such mutations 
were reviewed in the dystrophin gene (31). 
Among them, the double mutation E2910V-
N2912D in exon 59 was associated with a severe 
DMD (32). In the present study, with the aim of 
better understanding the role of the rod domain 
in dystrophin and the molecular basis of 
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muscular dystrophy, we analysed in vitro the 
consequences of the natural double mutation 
E2910V-N2912D on isolated single repeat 23 
from the rod domain of human dystrophin. We 
show that mutations induce significant changes 
in biophysical properties of the repeat, and then 
compare the homology-based molecular model 
structures of the wild type and mutated repeat 23 
of dystrophin. We propose that these changes in 
stability of a repeat from the rod domain could 
explain loss of mechanical properties of 
dystrophin and thus could explain cell muscle 
defects. 
 
Experimental procedures 
 
Materials. The pGEX-4T1 plasmid vector, 
GSTrapTM HP column were purchased from 
GE Healthcare. The ER2566 bacteria were 
supplied by Ozyme (St Quentin-en-Yvelines, 
France) and restriction enzymes by Promega 
(Charbonières, France). 
 
Cloning. The plasmid pTG11025, kindly 
provided by Dr S. Braun (Transgene, Strasbourg, 
France), is an E. coli plasmid that carries the 
cDNA encoding the full-length Dp427m isoform 
of human dystrophin (NCBI Nucleotide Data 
base NM-004006). Recombinant dystrophin rod 
domain wild-type and double mutated single-
repeat R23 were cloned downstream of the 
sequence of Glutathione S-transferase (GST) into 
pGEX-4T1 vector, using BamH I restriction site 
of the preScission thrombin recognition sequence 
and Xho I restriction site, as previously described 
for wild-type single-repeat R23 (20). Site-
directed mutagenesis was carried out by PCR 
using complementary oligonucleotide primers 
containing the double missense mutation 
(E2910V, N2912D) and primers previously used 
to clone single-repeat R23. The PCR-amplified 
fragment encoding mutated single-repeat R23 
was subcloned into pGEM-T Easy vector 
(Promega, Charbonnieres, France), sequenced by 
the dideoxy chain termination method (Genome 
Express, Meylan, France), and directly cloned in 
the pGEX-4T1 vector using BamHI and Xho I 
restriction sites. 
 
Boundaries of wild-type and double 
mutated single-repeat R23. Boundaries of 
recombinant R23 single-repeats were extended 
by assuming the original alignment of spectrin-
type triple-helical repeats in dystrophin as 
proposed previously (13). Both recombinant 
proteins were extended with 6 additional residues 
at the N-terminal end including the N-terminal 
Glycine-Serine dipeptide resulting from 
thrombin cleavage of GST-fusion proteins and 7 
additional residues at the C-terminal end 
according to Gratzer’s group (33,34), who 
recommended extending the constructs by 6 to 8 
residues to improve solubility and stability.   
Preparation of wild-type and double 
mutated single-repeat R23. Plasmid constructs 
were transformed into the protease-deficient 
Escherichia coli ER2566 strain, and cultures 
were then grown to an absorbance at 600 nm of 
0.5 at 37°C in LB broth supplemented with 
100 µg/ml ampicillin. Expression of GST fusion 
proteins was induced by addition of 1 mM 
isopropyl-beta-D-thiogalactopyranoside. After 
4h, bacteria were harvested by centrifugation at 
4000 g for 15 min at 4°C. As previously 
described (20), pellets from 500 ml culture were 
resuspended in 20 ml ice-cold lysis buffer 
(20mM Tris-HCl, pH7.5, 150 mM NaCl) and 
incubated with 0.5 mg.ml-1 lysozyme on ice for 
30 minutes before being broken up by sonication 
(U200S, UKA Labortechnic). After 
centrifugation at 10 000 g for 20 min at 4°C, 
filtered clarified extracts were loaded onto a pre-
equilibrated 5-ml GSTrapTM HP column at a flow 
rate of about 1 ml.min-1. The column was washed 
with ten column volumes of lysis buffer at a flow 
rate of 2 ml.min-1, and 250 units thrombin were 
then added. On-column cleavage took place for 
48 hours at 4°C and fractions of 1.5 ml were 
collected in the washing buffer. Fractions were 
concentrated on 3K Centricon, and the final 
purification step consisted of FPLC gel filtration 
on a Sephacryl S-200 column in lysis buffer 
containing 0.1 mM EDTA (TNE buffer). Protein 
purity was assessed by SDS PAGE and 
concentrations determined by BCA 
(bicinchoninic acid) protein assay with bovine 
albumin as standard. 
Circular dichroism measurements. Circular 
dichroism spectra were acquired at 20°C with a 
path length of 0.2 cm on a Jasco J-715 or 815 
spectropolarimeter, equipped with Peltier devices 
for temperature control. The molar ellipticity was 
calculated using a 100% α-helix coefficient of 
-36000 deg.cm2.dmol-1 at 222 nm as described 
previously (35). The thermal unfolding of each 
construct was monitored by CD at 222 nm at 
concentrations of 2.5-5 µM in TNE buffer with 
temperature increasing 1 deg/min from 15 to 
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85°C. CD signals were fitted either to two-state 
or three-state transitions. For the two-state 
transition, the data are fitted to the following 
equation:  
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where y is the CD signal at 222 nm at 
temperature T, αN and αD are the intercepts of the 
native and denatured states, respectively, while 
βN and βD are the slopes of the native and 
denatured states, respectively, ΔGUN is the free 
energy of unfolding and R is the gas constant in 
cal.mol-1.K-1. As described previously (36), this 
equation can be rewritten as equation 2 to 
facilitate non-linear regression analysis by 
SigmaPlot 10.0 in Windows:  
y = (αN+βNT)/{1+e4Tm(T-Tm)/TΔT}  
+ (αD+βDT)/{1+e4Tm(Tm-T)/TΔT}    (equation 2) 
where Tm is the melting temperature and ΔT is 
the width of the unfolding transition.  
In the case of a three-state unfolding 
process, equation 2 can be written as follows: 
y = (αN+βNT)/{1+e4Tm1(T-Tm1)/TΔT}  
+ (αI+βIT)/{1+e4Tm1(Tm1-T)/TΔT}  
+ (αI+βIT)/{1+e4Tm2(T-Tm2)/TΔT}  
+ (αD+βDT)/{1+e4Tm2(Tm2-T)/TΔT}  (equation 3) 
where αI is the intercept of the intermediate state, 
βI the slope of the intermediate state, Tm1 the 
melting temperature of the first transition 
between folded and intermediate state and Tm2 
the melting temperature of the second transition 
between the intermediate and denatured state. 
 
Steady-state fluorescence measurements 
and urea unfolding. Tryptophan fluorescence 
spectra of native or urea-treated proteins at 1µM 
in TNE buffer were recorded at 295 nm 
excitation wavelength (bandwidth, 8.4 nm) on a 
Fluorolog 3 spectrofluorometer (Horiba Jobin-
Yvon, France), using 10 x 4-mm quartz cuvettes 
at 20°C. After appropriate correction, we 
obtained the emission spectra of non denatured 
proteins and, for denatured proteins previously 
incubated for 2 hours in TNE with 0.25 to 8 M 
urea, we obtained the maximum wavelength 
(λmax) and intensity of fluorescence from the 
emission spectra. The unfolded fraction, y, was 
then plotted as a function of urea concentration, 
U, and fitted to a one-transition, two-state 
reversible process as described by (37) as given 
in the equation:  
y ={(αN+βNU) + (αD+βDU) e(mU–mU50%)/RT} / 
{1+e(mU – mU50%)/RT}                     (equation 4) 
where α is the intercept of the native (N) and 
denatured (D) states, β the slope of the native (N) 
and denatured (D) states, U50% is the urea 
concentration at the mid-point of denaturation, m 
is the slope of the transition between the native 
and denatured states, R is the gas constant, 1.987 
cal.mol-1.K-1 and T the temperature in K. The 
curves were fitted by non-linear regression with 
Sigma-plot 10.0 in Windows. The term mU50% in 
equation 4 is equal to the free energy of 
denaturation in the absence of urea, ΔGUN.  
In the case of a three-state unfolding 
process, the equation is as follows: 
y = (αN+βNU)/{1+e(mU – mU
a
50%)/RT}  
–0.5*(α+βIU)/{1+e(mU – mU
a
50%)/RT} 
+0.5*(αI+βIU)/{1+e(mU
a
50%– mU)/RT} 
+0.5*(αI+βIU)/{1+e(mU – mU
b
50%)/RT} 
–0.5*(αI+βIU)/{1+e(mU
b
50% – mU)/RT} 
+(αD+βDU)/{1+e(mU
b
50% – mU)/RT} (equation 5) 
where αI is the intercept of the intermediate state 
and βI the slope of the intermediate state, with 
Ua50% and Ub50% representing the urea 
concentrations at mid-denaturation for the first 
and second transitions, respectively. 
  
NMR spectroscopy. All the spectra were 
recorded at 303 K on a Bruker Avance 500 
spectrometer equipped with a triple-resonance 
cryoprobe (1H, 13C, 15N). The heteronuclear 
experiments were conducted on 15N-labelled 
protein obtained by expression in minimum 
media in the presence of 15N-labelled ammonium 
chloride. Purification was performed in the same 
way as the unlabelled protein. Using standard 
Bruker sequence, HSQC spectra were recorded 
in phase-sensitive mode in both dimensions 
using echo-antiecho TPPI gradient selection. 
1H-15N HSQC spectra were acquired with 16 
transients, with spectral windows of 16/32 ppm 
in the proton/nitrogen dimensions and the carrier 
set at the water frequency and 118 ppm, 
respectively. The relaxation delay used was 0.8 s. 
Spectra were processed with Topspin or 
NMRpipe (38) and visualized with Topspin or 
NMRview (39) on a Linux station. A matrix of 
2K x 256 points was acquired and zero-filled to 
2K x 1K points after apodization by shifted sine-
square multiplication and linear prediction in the 
F1 domain. 
 
Refolding kinetics by stopped-flow spectro-
fluorescence. Stopped-flow data were recorded 
on a BioLogic SFM-3, MOS-250 instrument 
(Grenoble, France). The dead time of the 
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stopped-flow device was 2.2 ms. For refolding 
measurements, stock solutions of 8M urea-
treated proteins were prepared for two hours in 
TNE buffer. The refolding reaction was initiated 
at 25°C by tenfold dilution of the urea-treated 
protein in TNE buffer. The final protein 
concentrations were 0.2-0.5 µM. The time-
dependent fluorescence of tryptophan changes 
were monitored at excitation and emission 
wavelengths of 295 nm and 345 nm, 
respectively. To determine rate constants, we 
used curves derived from the averages of at least 
ten individual kinetic data points after 
subtraction of the background urea buffer signal. 
Results were analysed by Biokine software 
(BioLogic). 
 
Structure calculation. Individual residues 
were assigned to the "a" to "g" positions within 
the heptads proposed by Winder (13) in 
predicted hydrophobic repeats. The fold 
recognition program mGenTHREADER (40,41) 
was run to detect the best templates for 
comparative modelling. The alignment proposed 
by mGenTHREADER is concordant with those 
proposed by Winder (13) and Kusonoki (36) 
with respect to the heptad motifs conserved in 
the spectrin repeats. Secondary structure 
predictions were performed via PSIPRED (42), 
incorporating four feed-forward neural networks 
that analyse the output obtained from 
PSI-BLAST. Homology models of wild type and 
mutated R23 proteins were built using 
MODELLER 9.2 software (43). MODELLER is 
a program based on satisfaction of spatial 
restraints generated on the target sequence using 
its alignment with the 3D structure of the 
templates. Additional restraints were fixed in 
compliance with the secondary structure 
prediction of PSIPRED. The loop modelling 
protocol of MODELLER 9.2 (44) was used to 
refine all loops of the selected model. Starting 
with random conformations, 20 structures were 
built up for each loop. The generated structures 
were assessed using MODELLER output as well 
as additional evaluations: the PROCHECK 
program was used to assess the stereochemical 
quality of the structures (45), supplemented by 
the following profile programs: ProSA-WEB 
(46), the web-based version of ProSA (47), 
VERIFY3D (48), ANOLEA (49,50) and by 
examination on a graphic display. A 
representative model was selected and its energy 
minimised with the SYBYL software (TRIPOS 
Inc., St Louis, MO). The secondary structures of 
the model were analysed and represented with 
the Pymol program (Delano Scientific). 
Hydrophobic and electrostatic potentials on the 
molecular surfaces were calculated using the 
rTools (Kristian Rother) and APBS (Adaptive 
Poisson-Boltzmann Solver) (51) software 
packages respectively, implemented in Pymol.  
http://bioinf.cs.ucl.ac.uk/psipred/ 
http://www.ncbi.nlm.nih.gov/blast/ 
http://www.doe-mbi.ucla.edu/Services/Verify_3D 
http://swissmodel.expasy.org/anolea/ 
 
 
RESULTS 
 
Protein characterization. Figure 1 shows 
the amino acid sequence of the R23 repeat of 
human dystrophin, along with the predicted 
secondary structure and alignment with the 
sequence of the repeat 16 from chicken brain 
α−spectrin R16-17 (PDB:1CUN) (52), which is 
the template selected for molecular modelling. 
According to Winder’s heptad-based alignment 
(13), the E>V and N>D mutations in positions 
2910 and 2912 of human dystrophin in R23 are 
located in helix C of the triple helix coiled coil, 
at positions "c" and "e" of the respective heptad. 
Both wild type and mutated R23 were expressed 
in E.coli as described in the experimental 
procedures, and purified in comparable amounts. 
N-terminal GST-tags were eliminated on an 
affinity chromatography column by thrombin 
cleavage and a second purification step was 
carried out by size-exclusion chromatography 
allowing to obtain pure proteins as verified by 
Coomassie blue stained SDS PAGE gels (Figure 
2A). The expected molecular masses of 16764 
and 16735 g.mol-1 were obtained for wild type 
and mutated R23 proteins, respectively, by mass 
spectrometry analysis (INRA Rennes). 
Analytical size-exclusion chromatography shows 
that both proteins are monomeric and 
monodisperse with calculated Stokes’ radii of 
2.4 nm. We conclude that the double mutation 
E2910V-N2912D does not induce self 
aggregation or measurable variation in frictional 
coefficient of the protein. The secondary 
structure of both proteins in solution at 20°C was 
analysed by circular dichroism. The spectra 
exhibits similar feature (Figure 2B), with 
canonical helical double minima at 208 and 
222 nm. The calculation of secondary structures 
indicates that wild type and mutated R23 have 
helical ratios of 83% and 81%, respectively, 
these values being characteristic of the α-helical 
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structure of spectrin-like repeats (53). No 
significant difference as regards shape and 
maximum emission wavelength can be detected 
between wild type and mutated R23 in the 
intrinsic fluorescence spectra of the four 
tryptophan residues (Figure 2C). Nevertheless, 
1D 1H NMR spectra (Figure 3A) show that WT 
and the mutant exhibit differences in the 
tryptophan indole proton area around 10 ppm, 
suggesting a slight change in the chemical 
environment of one or several tryptophan 
residues. Modifications around tryptophan 
residue(s) are also consistent with the changes 
observed in the strongly upfield-shifted methyl 
resonances. These shifts are consistent with the 
close proximity of methyl protons to the 
aromatic rings of the tryptophan. Overall, the 
proton spectra for both proteins are characteristic 
of structured protein species. Amide protons of 
the protein are spread out over 2 ppm and the 
several methyl protons are shielded around 0 
ppm. The 2D 1H-15N spectra HSQC shown on 
Figure 3B display a relatively good dispersion 
for both proteins. On both maps, many cross 
peaks are found at positions compatible with a 
large structural similarity between the proteins. 
However, about 30 % connectivities, are strongly 
modified when comparing the two spectra.  
 
Unfolding-Refolding. Thermal transition 
curves of both proteins were followed up by 
observing changes in CD intensity at 222 nm 
(Figure 4A). The results suggest that wild-type 
R23 is denatured in a single-step process with a 
melting temperature of 66.6°C, while the 
secondary structure of the R23 E2910V-N2912D 
mutant is clearly lost in a two-step process with 
two apparent melting temperatures of 44.5 and 
61.6°C, respectively.  
The urea denaturation data on Figure 4B 
show that wild-type protein is denatured in a 
single-step process with a urea concentration of 
4.90 M at mid-denaturation. The mutant exhibits 
a slight first unfolding phase with a urea mid-
denaturation value of 2M, and then a second 
unfolding transition with a mid-denaturation urea 
concentration of 4.15 M. Figure 4C shows the 
refolding kinetics of R23 and R23 E2910V-
N2912D monitored by stopped-flow tryptophan 
fluorescence, these proteins being first unfolded 
in 8.0 M urea and then rapidly diluted to a final 
urea concentration of 0.8 M at 25°C. The data 
were fitted to either one or two exponentials. For 
both proteins, the experimental curves best fit 
with single exponentials having rate constants of 
56±13 s-1 and 26±7 s-1 for wild-type and mutated 
R23, respectively. These values correspond to 
the means of three independent experiments. 
Experiments were repeated at 12 and 37°C. In all 
cases, single exponential data are obtained for 
both proteins, with significantly lower rate 
constants for the mutated R23 (data not shown). 
 
Molecular modelling. Structural features 
of the repeat 23 of human dystrophin. As 
expected, mGenTHREADER reveals that the 
best templates are spectrin-repeat containing 
proteins, particularly repeats 16-17 of the 
chicken brain α-spectrin (CBα16-17, 
PDB:1cun)(52) and repeats 8-9 of the human 
erythroid β-spectrin (HEβ8-9, PDB:1s35) (36). 
R23 shares 16.2% and 12.7% of sequence 
identity with CBα16 and HEβ8, respectively. As 
described previously (36), despite a relative low 
percentage of sequence identity, structures of 
individual spectrin-like repeats are nearly 
identical and provide good models for 
comparative modelling. The crystal structure of 
CBα16-17 provided the best 3D-structure 
template model for R23. Figure 1 presents the 
sequence alignments of R23 with CBα16. In 
consistency with PSIPRED predictions and 
considering the helical continuity in the linker 
regions between the end of one repeat and the 
beginning of the adjacent one, we assumed for 
R23 that the extremities of the A and C helices 
are fully helical. In consequence, we applied 
alpha helix restraints on two segments of R23 
that are not aligned with the CBα16 sequence, 
namely the N-terminal region (residues 2799 to 
2806) and the N-terminal extremity of the helix 
C (residues 2893 to 2900), which is predicted as 
helical by PSIPRED. Forty homology models 
were built up in this way. The models with 
GA341 scores higher than 0.6, with the lowest 
target function and DOPE score were evaluated 
with ProSA-web and VERIFY3D. In the selected 
model, the loops were then refined and all final 
structures were assessed using the strategy 
described in the experimental procedures. For the 
most representative result shown in Figure 5, 
VERIFY3D, ProSA and ANOLEA profiles were 
indicative of a high quality model with a mean 
force potential positive for VERIFY3D, a 
negative one for ANOLEA and ProSA with a 
ProSA global score of -6.32. After minimization, 
an excellent quality Ramachandran map is 
obtained, with no residues in the forbidden 
zones, 92.3% of residues in the most favoured 
regions and 6.9% in the allowed zone. The triple 
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helical coiled-coil fold of R23 is closely similar 
to those reported for spectrin repeats. The 
curvature observed in helix B is fully compatible 
with the presence of the semi-conserved proline 
residue in position 2860. The principal 
differences arise from the 20-residues insertion 
specific to R23, between helices B and C, which 
forms a long BC loop. The BC loop is longer in 
R23 than in CBα16, HEβ8 and the other 
dystrophin repeats, so it does not align with the 
template. We extensively refined it using the 
loop module of MODELLER. The best BC loop 
structures show an alpha helix turn from residue 
2880-2884 which is not predicted by PSIPRED.  
Inset in Figure 5 shows an enlargement of 
the area bearing the double mutation. We used 
MODELLER to build the model of the R23 
E2910V-N2912D protein from the R23 model, 
the conformation of the mutant side chain being 
optimized by a conjugate gradient and refined 
using molecular dynamics. The mutated residues 
are located in positions "c" and "e" in the third 
heptad hydrophobic repeat pattern of helix C (see 
Figure 1). According to the selected model, some 
hydrophobic residues lie on the inward-facing 
surface of the helices and likely control stability 
of R23 in the mutated area. These comprise 
A2908 and V2911, the "a" and "d"  residues in 
helix C, which interact in a hydrophobic cluster 
with the corresponding "a" and "d"  residues in 
helices A (L2814 and L2917) and B (I2862 and 
T2865).  
The residues mutated in the dystrophic 
pattern are in heptad positions "c" (E2910V) and 
"e" (N2912D), and surround the stabilizing 
residue "a" (V2911) in the heptad. As these two 
residues are in contact with the aqueous phase, 
we next used the rTools and the APBS software 
package to calculate hydrophobic and 
electrostatic surface scores for the whole R23 
WT and mutated repeat. In figure 6A is shown 
the ribbon plot of the chain fold. An examination 
of the hydrophobic surface properties, Figure 6B, 
reveals only a slight change between the WT and 
the mutated whole repeat in the E2910V 
substitution area. Electrostatic surface analysis of 
both proteins is shown on Figure 6C. The blue 
and red colouring represents the positive and 
negative mean charge surfaces, respectively. As 
expected from primary structure analysis, the 
whole repeat exhibits a global negative charge. 
In the E2910 area, a slight change in averaged 
negative charge is observed in the electrostatic 
surface following the E>V substitution, while a 
much significant increase of negative surface 
charge is observed on the opposite face of the 
repeat in the area corresponding to the location 
of the N2912D substitution (circled area). To 
assess the features that might induce repeat 
stability of the R23 repeat, we then analysed the 
surface properties of individual helices.  
Figure 7 shows single side views of 
electrostatic surfaces of separated helices of R23; 
helices are represented in their twisted structure 
from the model. Uncharged residues, indicated in 
white, are located on a line along each individual 
helix (dashed lines). They correspond to the "a" 
and "d" residues in heptads forming the 
hydrophobic interaction core between the three 
helices. For wild type R23, these models clearly 
show that each of the three helices exhibits a 
dipolar structure. Strong complementary 
electrostatic bonds between opposite mean 
charges of dipolar antiparallel helices likely 
contribute strongly to folding and/or stability of 
the triple helical coiled coil repeat. Interestingly, 
the electrostatic surface of helix C in the R23 
E2910V-N2912D mutant exhibits a significantly 
increased negative charge in the mutated area 
when compared to the wild type helix C which 
exhibit uncharged and hydrophobic residues in 
this area (dotted frame). This change could 
explain the loss of stability experimentally 
determined in the mutated protein. 
 
DISCUSSION 
 
The aim of our work was to understand how 
point mutations could affect the properties of one 
repeat of the dystrophin rod domain and lead to a 
severe Duchenne’s muscular dystrophy. We 
focused on the R23 repeat of the rod domain, 
which contained a double mutation in a 
dystrophic patient (31,32) and we evidenced a 
decreased stability of the repeat of the rod 
domain bearing the mutation.  
Investigations into the biological function of 
the dystrophin-glycoprotein complex suggest that 
it has an important mechanical function in 
stabilizing sarcolemma against stresses imposed 
during muscle contraction or stretching (54). 
Dystrophin-deficient muscle exhibits 
abnormalities in cell function that are not clearly 
understood and the various aspects of dystrophin 
function remain poorly known. Nevertheless, its 
cellular location as well as its association with 
the actin network and membrane-spanning 
β-dystroglycan suggest a role in the mechanical 
coupling of the fibre membrane and intracellular 
forces (55). The rod domain of dystrophin is 
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thought to function as a molecular spring or 
shock absorber, assuming that certain parts of the 
rod domain function as elastic elements (23,56). 
The determinants of rigidity and flexibility of the 
rod domain have to be highlighted. We 
previously showed that the distal part of the rod 
domain, R20-24, comprising the repeat 23 
exhibited no binding to lipids but very high 
thermal and urea stability (20). 
Wild type and mutant R23, both with 
flanking peptide extensions at the end of the 
canonical motifs, were expressed as fusion 
proteins in E.coli and further purified. Following 
removal of the N-terminal GST tag during the 
purification step, both proteins were obtained as 
soluble monomers. The amount of α-helix as 
measured by circular dichroism is in good 
agreement with a proper spectrin-like repeat 
folding. As reported by other authors (33,34), the 
small sequence extensions likely prevent fraying 
of the helices at the termini of the isolated 
repeats, but are unlikely to interact with other 
residues. At low temperatures, we found nearly 
identical α-helicities for the wild-type and 
mutant proteins. This indicates that the valine 
and aspartic acid side chains present in the 
mutant (V2910, D2912) are compatible with 
proper folding of the triple α-helix coiled-coil 
repeat. We also conclude from hydrodynamic 
behaviour in size exclusion chromatography that 
the slight changes observed in hydrophobic and 
electrostatic surface properties between wild type 
and mutated whole repeat R23 do not induce in 
vitro self aggregation or proteolysis. We clearly 
demonstrate that the double E2910V-N2912D 
mutation induces a strong reduction of thermal 
and chemical stability. Nevertheless, according 
to comparative refolding velocity analysis in 
vitro, we can infer that the R23 repeat containing 
the double mutation might follow a folding 
process leading to a canonical coiled-coil 
structure that exhibits a reduced stability.  
The amino acid substitutions analysed in the 
present study do not directly concern the 
hydrophobic stabilizing coiled-coil residues in 
positions "a" and "d" of the characteristic heptads 
spectrin-like repeats, that are known to induce a 
dramatic loss of stability of a spectrin single 
repeat if mutated (53), but those located at the 
"c" (E2910V) and "e" (N2912D) positions 
flanking the stabilizing valine residue in "d" 
heptad position. We can assume that these 
mutations probably have a limited effect on the 
R23 global fold. To investigate the structural 
features of the R23 repeat and the determinants 
involved in the loss of stability of mutated R23, 
we have built a homology model and made NMR 
experiments. Homology modelling allowed us to 
determine the global structure of the R23 repeat, 
thus it was possible to identify residues near the 
mutation site and to speculate about intra or 
inter-helical interactions that likely control the 
stability of R23. Since yields of production of 
highly stable 15N labelled-R23 repeat are 
important, it was possible to obtain valuable 
information from NMR experiments. At this 
stage, we observed that about 30% of the signals 
have significant chemical shifts variations on the 
15N HSQC spectrum, which means that about a 
third of the mutant R23 residues have their local 
environment modified compared to the R23 WT. 
It is interesting to note the impact of the mutation 
on the spectra obtained, while secondary 
structures are conserved. To give more insight on 
the mutation effect, we hope to obtain the 
assignment of the R23 repeat in order to identify 
the shifted residues in mutant R23 and if possible 
determine structures of both proteins. However, 
assignment of the coiled coil proteins is more 
difficult than for globular proteins, due to a 
poorer dispersion of the resonances and the small 
number of long-range constraints (57). Indeed, 
preliminary studies (data not shown) on a 
double-labelled 15N-13C WT R23 show that the 
Cα and Cβ signals are particularly degenerated 
and make the resonance of the R23 backbone 
difficult to assign. 
The models obtained by comparative 
modelling permit us to propose several 
hypothesis that could explain the difference of 
stability between the WT and mutated R23. 
Molecular modelling of the R23 repeat is based 
on the homology with the chicken brain 
α-spectrin repeat 16 with respect with the 
“nested model” (33). As described in the results 
section, the scores and profiles obtained from the 
validation softwares are satisfactory. By 
examination of the model with the Pymol 
software, we can verify that the global features 
of a spectrin single repeat are satisfied. The 
residues "a" and "d" made hydrophobic 
interactions, lying on the inward facing surface 
of the helices. One notable hydrophobic cluster 
of the R23 coiled coil structure includes the two 
buried tryptophans W2820, in helix A, and 
W2915, in helix C. These observations fit well 
with the previously reported interactions between 
two conserved tryptophan residues, which 
represent a stabilizing feature through most of the 
spectrin-like repeats (58). Among these 
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canonical conserved tryptophans, W2915 in “a” 
heptad position appears in the model as the 
residue closest to the mutated area and more 
precisely close to the mutated residue D2912 in 
“e” heptad position while the mutated V2910 in 
“c” position is located on the opposite face of the 
coiled coil R23 repeat structure. It is likely that 
the N2912D mutation predominantly influence 
the behaviour of W2915, as suggested by NMR 
analysis. Indeed, the NMR data showed that the 
chemical environment of one of the four 
tryptophans was modified in mutant vs. WT. The 
two other tryptophan residues of R23 (W2807 in 
helix A and W2925 in helix C) are each located 
at the extremities of the triple helical coiled-coil 
structure and thus are unlikely to have an 
environment that could be significantly affected 
by the mutations. Consequently, we proposed 
that the double mutation destabilizes indirectly 
the hydrophobic cluster comprising these two 
conserved tryptophans facing each other. 
It has been shown that electrostatic 
interactions participate in structural stability of 
coiled coil spectrin single repeats (59). We 
observed that electrostatic potentials at the 
molecular surfaces of WT and mutant R23 were 
markedly different at the mutation site of helix 
C, resulting in differences by considering the 
whole triple helical repeat. Intra helix 
electrostatic bonds have been reported to 
contribute to coiled coil stability (60) In our 3D 
model, the proximity in helix C of the residue 
E2910 with K2906 or K2917 may suggest the 
existence of a stabilizing intrahelical salt bridge, 
that could be disrupted by the E2910V mutation. 
More noticeable is our observation that, when 
analysed individually, the anti-parallel helices A, 
B and C from the R23 repeat, exhibit opposite 
electrostatic potentials highlighting the existence 
of interhelical electrostatic forces between these 
dipolar charged helices, that could reinforce the 
stability of the triple helical repeat R23.The 
apparition of a negative charge in the middle of 
helix C, while hydrophobic and uncharged in 
WT R23, could be also involved in the loss of 
stability of mutant R23.  
In summary, the model presented here 
supports the hypothesis that folding and stability 
of repeats of dystrophin is driven by hydrophobic 
as well as long-range electrostatic interactions. 
Otherwise differences are more important on the 
electrostatic surfaces than the hydrophobic one 
between the WT and the mutated R23 models, 
influenced by the nature of the mutations 
themselves. 
Although the role of the rod domain is still 
poorly understood, it may ensure the flexibility 
of dystrophin and thus represent a central 
function of the dystrophin protein (61). 
Cooperative effects between spectrin repeats 
have been described in other proteins belonging 
to this family (17). Due to structural similarities, 
such cooperative folding properties might occur 
in the dystrophin rod domain and thus form part 
of native molecular events involved in the whole 
dystrophin molecule. The changes in stability 
properties following two mutations within R23 
as demonstrated here, if transposed to the whole 
R20-24 domain (20) or to the whole dystrophin 
protein, might lead to dramatic differences in 
muscle cell life. In that field, one can consider 
than the C-terminus part of dystrophin is 
involved in binding to the membrane 
glycoprotein complex. These interactions have 
been characterized at the residue level (62), but 
may be regulated by other domains within or 
close to the C-terminus. The R20-24 sub-domain, 
which includes the R23 repeat studied in the 
present paper, is located between two hinges and 
has been shown to exhibit a remarkable high 
stability but no lipid binding properties (20). The 
R20-24 subdomain is thus unlikely to act on its 
own as an elastic shock absorber. Due to the 
close proximity of this part of the rod domain to 
the beta-dystroglycan-binding domain of 
dystrophin, we can hypothesise that beta-
dystroglycan binding requires an adjacent 
domain highly stable by itself or stabilized 
through interaction with a yet unknown partner.  
To conclude, we made use in this study of some 
of the rare pathogenic missense mutations, with 
an abundance estimated at less than 2% which 
are found in the dystrophin gene (31). Our data 
support a critical role for the rod domain in 
different aspects of dystrophin function. In 
addition to linkage to the plasma membrane 
through lipids and beta-dystroglycan (20), the 
stability and proper mechanical behaviour of the 
rod domain appear as fundamental. Decreased 
stability of R23 repeat may contribute to 
mechanically weakened dystrophin-deficient 
muscle. Although the mutations studied here 
would not affect the integrity of the dystrophin 
glycoprotein complex, they might modify the 
mechanical properties of certain parts of the 
molecule. Analysis of the human wild-type R23 
and DMD E2910V-N2912D R23 structures 
obtained from comparative modelling provides 
some insights into structural differences between 
wild-type and DMD forms of dystrophin.  
REFERENCES 
 
1. Darras, B. T., Blattner, P., Harper, J. F., Spiro, A. J., Alter, S., and Francke, U. (1988) Am J 
Hum Genet 43(5), 620-629 
2. Koenig, M., Beggs, A. H., Moyer, M., Scherpf, S., Heindrich, K., Bettecken, T., Meng, G., 
Muller, C. R., Lindlof, M., Kaariainen, H., and et al. (1989) Am J Hum Genet 45(4), 498-506 
3. White, S., Kalf, M., Liu, Q., Villerius, M., Engelsma, D., Kriek, M., Vollebregt, E., Bakker, 
B., van Ommen, G. J., Breuning, M. H., and den Dunnen, J. T. (2002) Am J Hum Genet 71(2), 
365-374 
4. Chaturvedi, L. S., Mukherjee, M., Srivastava, S., Mittal, R. D., and Mittal, B. (2001) Exp Mol 
Med 33(4), 251-256 
5. Eraslan, S., Kayserili, H., Apak, M. Y., and Kirdar, B. (1999) Eur J Hum Genet 7(7), 765-770 
6. Ervasti, J. M., and Campbell, K. P. (1993) Curr Opin Cell Biol 5(1), 82-87 
7. Norwood, F. L., Sutherland-Smith, A. J., Keep, N. H., and Kendrick-Jones, J. (2000) Structure 
8(5), 481-491 
8. Huang, X., Poy, F., Zhang, R., Joachimiak, A., Sudol, M., and Eck, M. J. (2000) Nat Struct 
Biol 7(8), 634-638 
9. Koenig, M., and Kunkel, L. M. (1990) J Biol Chem 265, 4560-4566. 
10. Parry, D. A., Dixon, T. W., and Cohen, C. (1992) Biophys J 61(4), 858-867 
11. Speicher, D. W., and Marchesi, V. T. (1984) Nature 311(5982), 177-180 
12. Pantazatos, D. P., and MacDonald, R. I. (1997) J Biol Chem 272(34), 21052-21059 
13. Winder, S. J., Gibson, T. J., and Kendrick-Jones, J. (1995) FEBS Lett 369(1), 27-33 
14. Winograd, E., Hume, D., and Branton, D. (1991) Proc Natl Acad Sci U S A 88(23), 10788-
10791 
15. Kahana, E., Marsh, P. J., Henry, A. J., Way, M., and Gratzer, W. B. (1994) J Mol Biol 235(4), 
1271-1277 
16. Le Rumeur, E., Fichou, Y., Pottier, S., Gaboriau, F., Rondeau-Mouro, C., Vincent, M., Gallay, 
J., and Bondon, A. (2003) J Biol Chem 278, 5993-6001 
17. Batey, S., Randles, L. G., Steward, A., and Clarke, J. (2005) J Mol Biol 349(5), 1045-1059 
18. An, X., Guo, X., Zhang, X., Baines, A. J., Debnath, G., Moyo, D., Salomao, M., Bhasin, N., 
Johnson, C., Discher, D., Gratzer, W. B., and Mohandas, N. (2006) J Biol Chem 281(15), 
10527-10532 
19. Saadat, L., Pittman, L., and Menhart, N. (2006) Biochim Biophys Acta 1764, 943-954 
20. Legardinier, S., Hubert, J. F., Le Bihan, O., Tascon, C., Rocher, C., Raguenes-Nicol, C., 
Bondon, A., Hardy, S., and Le Rumeur, E. (2008) Biochim Biophys Acta 1784(4), 672-682 
21. Phelps, S. F., Hauser, M. A., Cole, N. M., Rafael, J. A., Hinkle, R. T., Faulkner, J. A., and 
Chamberlain, J. S. (1995) Hum Mol Genet 4, 1251-1258 
22. Harper, S. Q., Hauser, M. A., DelloRusso, C., Duan, D., Crawford, R. W., Phelps, S. F., 
Harper, H. A., Robinson, A. S., Engelhardt, J. F., Brooks, S. V., and Chamberlain, J. S. (2002) 
Nat Med 8, 253-261 
23. Rybakova, I., Humston, J., Sonneman, K., and Ervasti, J. (2006) J Biol Chem 281, 9996-
10001 
24. Wang, B., Li, J., Qiao, C., Chen, C., Hu, P., Zhu, X., Zhou, L., Bogan, J., Kornegay, J., and 
Xiao, X. (2008) Gene Ther 15(15), 1099-1106 
25. Amann, K. J., Guo, A. W., and Ervasti, J. M. (1999) J Biol Chem 274(50), 35375-35380 
26. Hanft, L. M., Rybakova, I. N., Patel, J. R., Rafael-Fortney, J. A., and Ervasti, J. M. (2006) 
Proc Natl Acad Sci U S A 103(14), 5385-5390 
27. England, S. B., Nicholson, L. V., Johnson, M. A., Forrest, S. M., Love, D. R., Zubrzycka-
Gaarn, E. E., Bulman, D. E., Harris, J. B., and Davies, K. E. (1990) Nature 343(6254), 180-
182 
28. Le Rumeur, E., Pottier, S., Da Costa, G., Metzinger, L., Mouret, L., Rocher, C., Fourage, M., 
Rondeau-Mouro, C., and Bondon, A. (2007) Biochim Biophys Acta 1768(3), 648-654 
29. Sheetz, M. P., Sable, J. E., and Dobereiner, H. G. (2006) Annu Rev Biophys Biomol Struct 35, 
417-434 
30. Kahana, E., Flood, G., and Gratzer, W. B. (1997) Cell Motil Cytoskeleton 36(3), 246-252 
 10  
31. Roberts, R. G., Gardner, R. J., and Bobrow, M. (1994) Hum Mutat 4(1), 1-11 
32. Lenk, U., Hanke, R., and Speer, A. (1994) Neuromuscul Disord 4(5-6), 411-418 
33. Calvert, R., Kahana, E., and Gratzer, W. B. (1996) Biophys J 71(3), 1605-1610 
34. Kahana, E., and Gratzer, W. B. (1995) Biochemistry 34(25), 8110-8114 
35. Chen, G. C., and Kane, J. P. (1986) Methods Enzymol 128, 519-527 
36. Kusunoki, H., MacDonald, R., and Mondragon, A. (2004) Structure 12, 645-656 
37. MacDonald, R., and Pozharski, E. (2001) Biochemistry 40, 3974-3984 
38. Delaglio, F., Grzesiek, S., Vuister, G. W., Zhu, G., Pfeifer, J., and Bax, A. (1995) J Biomol 
NMR 6(3), 277-293 
39. Johnson, B. A., and Blevins, R. A. (1994) J Biomol NMR 4(5), 603-614 
40. Jones, D. T. (1999) J Mol Biol 287(4), 797-815 
41. McGuffin, L. J., Bryson, K., and Jones, D. T. (2000) Bioinformatics 16(4), 404-405 
42. Jones, D. T. (1999) J Mol Biol 292(2), 195-202 
43. Sali, A., and Blundell, T. L. (1993) J Mol Biol 234(3), 779-815 
44. Fiser, A., Do, R. K., and Sali, A. (2000) Protein Sci 9(9), 1753-1773 
45. Laskowski, R. A., Rullmannn, J. A., MacArthur, M. W., Kaptein, R., and Thornton, J. M. 
(1996) J Biomol NMR 8(4), 477-486 
46. Wiederstein, M., and Sippl, M. J. (2007) Nucleic Acids Res 35(Web Server issue), W407-410 
47. Sippl, M. J. (1993) J Comput Aided Mol Des 7(4), 473-501 
48. Luthy, R., Bowie, J. U., and Eisenberg, D. (1992) Nature 356(6364), 83-85 
49. Sippl, M. J. (1990) J Mol Biol 213(4), 859-883 
50. Melo, F., and Feytmans, E. (1998) J Mol Biol 277(5), 1141-1152 
51. Baker, R. D. (2001) Lifetime Data Anal 7(1), 65-83 
52. Grum, V. L., Li, D., MacDonald, R. I., and Mondragon, A. (1999) Cell 98, 523-535 
53. Kahana, E., and Gratzer, W. B. (1991) Cell Motil Cytoskeleton 20(3), 242-248 
54. Judge, L. M., Haraguchiln, M., and Chamberlain, J. S. (2006) J Cell Sci 119(Pt 8), 1537-1546 
55. Claflin, D. R., and Brooks, S. V. (2008) Am J Physiol Cell Physiol 294(2), C651-658 
56. McGough, A. (1999) Curr Biol 9(23), R887-889 
57. Schnell, J. R., Zhou, G. P., Zweckstetter, M., Rigby, A. C., and Chou, J. J. (2005) Protein Sci 
14(9), 2421-2428 
58. MacDonald, R. I., Musacchio, A., Holmgren, R. A., and Saraste, M. (1994) Proc Natl Acad 
Sci U S A 91(4), 1299-1303 
59. Djinovic-Carugo, K., Gautel, M., Ylanne, J., and Young, P. (2002) FEBS Lett 513(1), 119-123 
60. Kammerer, R. A., Jaravine, V. A., Frank, S., Schulthess, T., Landwehr, R., Lustig, A., Garcia-
Echeverria, C., Alexandrescu, A. T., Engel, J., and Steinmetz, M. O. (2001) J Biol Chem 
276(17), 13685-13688 
61. Bhasin, N., Law, R., Liao, G., Safer, D., Ellmer, J., Discher, B. M., Sweeney, H. L., and 
Discher, D. E. (2005) J Mol Biol 352(4), 795-806 
62. Hnia, K., Zouiten, D., Cantel, S., Chazalette, D., Hugon, G., Fehrentz, J. A., Masmoudi, A., 
Diment, A., Bramham, J., Mornet, D., and Winder, S. J. (2007) Biochem J 401(3), 667-677 
 
 
FOOTNOTES 
 
This work is supported in part by the “Association Française contre les Myopathies” (AFM). Sébastien 
Legardinier and Baptiste Legrand are recipient of grants from the “Conseil Régional de Bretagne”. 
The authors wish to thank C. Rocher (UMR CNRS 6026), MR Allo and S. Pastezeur (UMR CNRS 
6061) for technical assistance and D. Mollé (INRA STLO) for mass spectrometry facilities. M.S.N. 
Carpenter post-edited the English style. 
 
 11  
 12  
FIGURE LEGENDS 
 
Fig.1. Sequence alignment of the repeat R16 of chicken brain alpha spectrin (CBα16) and the repeat 
R23 of human dystrophin (R23 WT). Alignment is represented using ESPript, numbers correspond to 
the CBα16 sequence. Identical residues are represented as white letters on a red background while 
similar residues are represented as red letters. The 3 α-helices (HA, HB, HC) for template CBα16 and 
those predicted by PSIPRED for R23 are represented as squiggles. One heptad is enlarged in the inset, 
showing the localisation of the E2910V and N2912D mutations in helix C of R23 and their assignment 
in the heptad pattern.  
 
Fig.2. Comparison of wild type and mutant R23 biochemical properties. A. SDS-PAGE analysis of 
purified R23 WT and E2910V-N2912D revealed by Coomassie blue staining. B. CD spectra of R23 
WT (circle) and E2910V-N2912D (triangle) at 2.5 µM. CD spectra were obtained at 20°C in TNE 
buffer, pH 7.5. C. Tryptophan fluorescence spectra of R23 WT (circle) and E2910V-N2912D 
(triangle) at 1 µM in TNE buffer at 20°C. Excitation wavelength is 295 nm with spectra recorded 
between 310 and 420 nm. 
 
Fig.3. NMR analysis. A. 1D 1H NMR spectra of the R23 WT (bottom) and R23 E2910V-N2912D 
(top). B. Overlay of 1H-15N 2D HSQC spectra of the R23 WT (black) and E2910V-N2912D (red).  
 
Fig.4. Unfolding and refolding of wild type and mutant R23. A. Thermal unfolding as measured by 
CD spectroscopy at 222 nm, unfolded fraction are plotted as described in methods. R23 WT (circle) 
follows a single step process (Tm 66.6°C) whereas R23 E2910V-N2912D (triangle) follows a two-step 
process (Tm1 44.5°C and Tm2 61.6°C). B. Urea unfolding as measured by variation of maximum 
wavelength in tryptophan fluorescence spectra, unfolded fraction are plotted as described in methods. 
R23 WT (circle) follows a single step process (U50% 4.9M) whereas R23 E2910V-N2912D (triangle) 
follows a two-step process (Ua50% 2M and Ub50%  4.2M). C. Refolding kinetics observed by 
stopped-flow fluorimetry after a one tenth dilution of R23 WT and R23 E2910V-N2912D, unfolded in 
8.0 M urea. Final protein concentrations are of 0.2 μM. Measurements were performed at 25 °C by 
monitoring fluorescence emission at 345 nm after excitation at 295 nm. Curves show the averages of 
at least ten individual kinetics. The rate constants k were obtained by fitting exponential functions to 
stopped-flow data.  
 
Fig.5. Molecular modelling of wild type R23. Pymol representation of the R23 WT global fold. N and 
C-terminus and helices numbering (HA, HB, HC) are indicated. Important amino-acids are coloured 
and displayed in stick representation: W2807, W2820, W2915 and W2925 in yellow, E2910 and 
N2912 in green and P2860 in red. The inset shows, enlarged and rotated, the area of the mutation with 
charged residues also in colour (blue and red for positive and negative residues respectively). 
 
Fig.6. Surface properties of the wild type and mutant R23. A. Orientation of the molecule. B. 
Hydrophobic potentials at the molecular surface of R23 WT (left) and R23 E2910V-N2912D (right). 
Surface is coloured with increasing hydrophobicity from green to red. C. Electrostatic potentials at the 
molecular surface of R23 WT (left) and R23 E2910V-N2912D (right). Surface is coloured with 
increasing electrostatic potentials from red to blue. The areas of main differences between WT and 
E2910V-N2912D are circled with dotted lines. 
 
Fig.7. Electrostatic potentials of each individual helix HA, HB and HC for wild type and mutant R23. 
Surface is coloured with increasing electrostatic potentials from red to blue. Numbers corresponding to 
first and last amino acids of each helix are mentioned. Dashed lines represent the location of the 
hydrophobic residues a and d by which the helices interact. The areas of main differences between WT 
and E2910V-N2912D are framed with dotted line. 
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